Anaplastic oligodendrogliomas with 1p19q codeletion have a proneural gene expression profile

Area of Science:

• Neuro-oncology
• Genomics
• Molecular Biology

Background:

• High-grade gliomas (HGGs) present distinct genetic alterations: 1p19q codeletion and EGFR amplification.
• These alterations are mutually exclusive and predict significantly different patient outcomes.
• Understanding these molecular differences is crucial for targeted therapies.

Purpose of the Study:

• To investigate the gene expression profiles of HGGs with 1p19q codeletion versus EGFR amplification.
• To identify molecular markers that distinguish these two glioma subtypes.
• To explore the cellular origin and differentiation pathways in these gliomas.

Main Methods:

• Microarray gene expression profiling of 13 HGGs (4 with 1p19q codeletion, 9 with EGFR amplification).
• Comparative Genomic Hybridization (CGH)-array for genetic characterization.
• Unsupervised clustering analysis to distinguish glioma groups.
• Validation using real-time RT-PCR on 22 key genes in an independent series of 16 gliomas.
• Immunohistochemical analysis of alpha-internexin expression.

Main Results:

• Two distinct gene expression profiles were identified, clearly separating HGGs with 1p19q codeletion from those with EGFR amplification.
• Gliomas with 1p19q codeletion exhibited gene expression patterns resembling normal brain tissue, including significant expression of neuronal genes.
• Gliomas with EGFR amplification showed profiles similar to glioblastoma cancer stem cells.
• Alpha-internexin, a neuronal marker, was specifically expressed in tumor cells of 1p19q codeleted gliomas.

Conclusions:

• The findings support neuronal differentiation in oligodendrogliomas with 1p19q codeletion.
• This suggests that the cell of origin for 1p19q codeleted gliomas may be a bi-potential progenitor capable of differentiating into neurons and oligodendrocytes.
• These distinct molecular profiles have implications for glioma classification and therapeutic strategies.